Most adult survivors of childhood cancer consider themselves in good health

September 23, 2003

(MEMPHIS, TENN.--September 24, 2003) Adult survivors of childhood cancer generally consider themselves to be in good health, even though more than 40 percent of such survivors indicated that at least one aspect of their health has been affected by the disease. Researchers from the Childhood Cancer Survivor Study (CCSS), which included a team from St. Jude Children's Research Hospital, published the finding in the September issue of the Journal of the American Medical Association.

The study found that only 10.9 percent of adult survivors reported fair or poor health, even though 43.6 percent reported some sort of impairment linked to childhood cancer or its treatment. Factors associated with reporting at least one health-related problem were the same as those in the general population: being female, having no more than a high school education and having an annual income of less than $20,000.

The results were based on health assessments of 9,535 adult participants of the CCSS, a consortium of survivors treated at 25 pediatric cancer centers across the United States and Canada. The investigators studied six specific aspects of health: general health; mental health; functional status (ability to perform personal care or everyday tasks, such as eating, bathing and household chores); activity limitations (such as moving a table or bowling); cancer-related pain; and cancer-related anxieties and fears. The study compared survivor health to that of 2,916 randomly selected siblings of the survivors. None of the siblings were childhood cancer survivors. The multi-center investigation was undertaken to evaluate the late physical and psychological health effects of treatment for childhood cancer.

"Childhood cancer and its treatment have a significant potential long-term impact on the physical and psychological health of the survivor," said Melissa M. Hudson, M.D., a member of the St. Jude Hematology-Oncology program and director of the After Completion of Therapy Clinic. "But our findings indicate that in large part, adult survivors of childhood cancer have a very good chance of living normal lives." Hudson is the report's lead author.

However, the investigators found that patients who were treated for a bone or central nervous system (CNS) tumor were more likely to report a negative impact on their long-term health than those treated for leukemia. Bone tumor survivors were more likely than leukemia survivors to report limitations in performing daily activities and pain as a result of the cancer or its treatment. Adult CNS-tumor survivors were more likely to report functional problems and lower general health status.

Treatment for bone and CNS tumors typically involves intensive surgery, radiation and chemotherapy, so it is not surprising that survivors of these malignancies experience more health impairment, according to Hudson.

The findings could help identify high-risk childhood cancer survivors who will be more likely to require intervention by health care providers in order to achieve optimal long-term health after treatment.

"Our findings underscore the need for physicians caring for young adult cancer survivors to be informed about treatment exposures and their potential long-term adverse effects," Hudson said. "Evaluations of survivors should address potential adverse effects on both physical and emotional health and provide interventions to improve health deficits predisposed by the childhood cancer experience."

Other authors of the study include Ann C. Mertens, James G. Gurney, Leslie R. Robison, Hegang Chen, and Mark Yeazel (University of Minnesota); Yutaka Yasui (Fred Hutchinson Cancer Research Center); Wendie Hobbie (Children's Hospital of Philadelphia); Christopher J. Recklitis (Dana Farber Cancer Institute); Neyssa Marina (Stanford University Medical Center); and Kevin C. Oeffinger (University of Texas Southwestern Medical Center).
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. Founded by late entertainer Danny Thomas and based in Memphis, Tenn., St. Jude freely shares its discoveries with scientific and medical communities around the world. No family ever pays for treatments not covered by insurance, and families without insurance are never asked to pay. St. Jude is financially supported by ALSAC, its fund-raising organization. For more information, please visit

St. Jude Children's Research Hospital

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to